The new HTA guides 2017 could be up to their predecessors

From the first reports, back in 1920, we have studied, recognized and documented the excess of events associated with arterial hypertension. This linear relationship between the level of blood pressure and the risk of stroke, is evident in all adults beyond age, sex or race, transforming high blood pressure into the highest target of global public health.

Las nuevas guías Europeas de Hipertensión contrastan con las Americanas

The greatest impact of reducing hypertension was observed in adults between 60 and 74 years, where a decrease in systolic pressure from 148 to 129 mm Hg led to a 50% reduction in stroke risk, and a decrease from 188 to 156 mm Hg to a reduction of 90% of the risk!


Read also: New High Blood Pressure Guidelines.


These lower levels of blood pressure observed were, obviously, thanks to the pharmacological treatment of this age group. However, lower levels were also observed in the group between 20 and 29 years, which suggests that prevention and non-pharmacological treatment are also very effective.

From the end of the 90s until 2017, the evidence from randomized clinical studies and epidemiological studies was incorporated into the guidelines to detect, treat, control and prevent hypertension in the most effective way possible.

With each new guide that redefined objectives and improved treatment protocols, a decrease in the population’s blood pressure and a reduction in stroke risk was observed. These improvements cannot be attributed to the guidelines themselves, but rather to the implementation by doctors of their recommendations in daily clinical practice.


Read also: Patients with Resistant Hypertension: Nearly 50% doesn’t take medication.


The reduction in the risk of stroke due to the decrease in blood pressure has been proposed as the greatest achievement of public health in the last 50 years. This achievement is not more than the result of the application in daily clinical practice of recommendations based on evidence and adherence to treatment by patients.

We hope that the ambitious recommendations of the new hypertension guidelines of 2017 can continue with the trend of their predecessors, since there is still a huge potential in improving the cerebrovascular health of the population.

Original title: Implications of New High Blood Pressure Guidelines for Stroke Primary and Secondary Prevention.


Subscribe to our weekly newsletter

Get the latest scientific articles on interventional cardiology

We are interested in your opinion. Please, leave your comments, thoughts, questions, etc., below. They will be most welcome.

More articles by this author

Pretreatment with DAPT in Acute Coronary Syndrome: An Ongoing Debate?

In acute coronary syndrome (ACS) dual antiplatelet therapy (DAPT) has become a fundamental pillar after percutaneous coronary intervention (PCI), preventing stent thrombosis and acute...

Transcatheter Pulmonary Valve Implantation with a Self-Expanding Valve: Outcomes at 3 Years

Pulmonary regurgitation (PR) is a common condition in patients who have undergone surgical repair of Tetralogy of Fallot or other pathologies involving the right...

SMART-CHOICE 3 | Efficacy and Safety of Clopidogrel vs Aspirin Monotherapy in High Risk Patients after Percutaneous Coronary Intervention

Courtesy of Dr. Juan Manuel Pérez. After post percutaneous coronary intervention (PCI) standard duration dual antiplatelet therapy (DAPT), the optimal long term monotherapy strategy is...

RACE Trial: Effect of Balloon Pulmonary Angioplasty and Riociguat on Right Ventricular Afterload and Function in Chronic Thromboembolic Pulmonary Hypertension

Even though pulmonary endarterectomy is the treatment of choice for chronic thromboembolic pulmonary hypertension (CTEPH), up to 40% of patients are not candidates because...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related Articles

SOLACI Sessionsspot_img

Recent Articles

Pretreatment with DAPT in Acute Coronary Syndrome: An Ongoing Debate?

In acute coronary syndrome (ACS) dual antiplatelet therapy (DAPT) has become a fundamental pillar after percutaneous coronary intervention (PCI), preventing stent thrombosis and acute...

Measuring Post-TAVI Gradients and Their Implications: Are Invasive and Echocardiographic Assessments Comparable?

Transcatheter aortic valve implantation (TAVI) is considered the treatment of choice for a significant proportion of patients with symptomatic aortic stenosis. Outcomes have improved...

Another Blow for Intra-Aortic Balloon Pumo Counterpulsation? Randomized Study on Its Use in Chronic Heart Failure Progressing to Cardiogenic Shock

Cardiogenic shock (CS) remains a condition with extremely high mortality (around 50%). While most therapies for this pathology have been studied in CS secondary...